id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-032891-pvijxcgi	Zhang, Joe	Veno-venous Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019: A Case Series	2020-09-25		.txt	text/plain	2583	140	39	RATIONALE: The use of veno-venous extracorporeal membrane oxygenation (VV-ECMO) in severe hypoxaemic respiratory failure from Coronavirus disease 2019 (COVID-19) has been described, but reported utilisation and outcomes are variable, and detailed information on patient characteristics is lacking. While VV-ECMO was associated with improved outcome during the H1N1 influenza pandemic (4, 5) , COVID-19 demonstrates features unique from other respiratory infections and early case-series have reported high mortality in patients on ECMO (6) (7) (8) . National criteria were adapted for the COVID-19 pandemic on the 10 th of April 2020 (11) to include clinical frailty scale ≤3 (12) , the use of the Respiratory ECMO Survival Prediction (RESP) score (13) to aid pre-ECMO decision-making (with RESP score ≤3 requiring agreement between at least two centres), and an exclusion of "refractory multi-organ failure". Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports	./cache/cord-032891-pvijxcgi.txt	./txt/cord-032891-pvijxcgi.txt